Cargando…
Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020562/ https://www.ncbi.nlm.nih.gov/pubmed/36928216 http://dx.doi.org/10.1038/s41523-023-00515-4 |
| _version_ | 1784908286534877184 |
|---|---|
| author | Agostinetto, Elisa de Azambuja, Evandro Lambertini, Matteo |
| author_facet | Agostinetto, Elisa de Azambuja, Evandro Lambertini, Matteo |
| author_sort | Agostinetto, Elisa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10020562 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100205622023-03-18 Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer Agostinetto, Elisa de Azambuja, Evandro Lambertini, Matteo NPJ Breast Cancer Matters Arising Nature Publishing Group UK 2023-03-16 /pmc/articles/PMC10020562/ /pubmed/36928216 http://dx.doi.org/10.1038/s41523-023-00515-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Matters Arising Agostinetto, Elisa de Azambuja, Evandro Lambertini, Matteo Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer |
| title | Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer |
| title_full | Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer |
| title_fullStr | Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer |
| title_full_unstemmed | Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer |
| title_short | Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer |
| title_sort | reply to: predict underestimates survival of patients with her2-positive early-stage breast cancer |
| topic | Matters Arising |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020562/ https://www.ncbi.nlm.nih.gov/pubmed/36928216 http://dx.doi.org/10.1038/s41523-023-00515-4 |
| work_keys_str_mv | AT agostinettoelisa replytopredictunderestimatessurvivalofpatientswithher2positiveearlystagebreastcancer AT deazambujaevandro replytopredictunderestimatessurvivalofpatientswithher2positiveearlystagebreastcancer AT lambertinimatteo replytopredictunderestimatessurvivalofpatientswithher2positiveearlystagebreastcancer |